09.12.2022 13:30

Nerve repair and regeneration market 2023-2027: Growth opportunities led by Abbott Laboratories and ALEVA NEUROTHERAPEUTICS SA - Technavio

Folgen
Werbung

NEW YORK, Dec. 9, 2022 /PRNewswire/ -- The nerve repair and regeneration market size is estimated to increase by USD 4,891.9 million from 2022 to 2027, with an accelerated CAGR of 11.23%, according to a recent market study by Technavio. This report also offers a 5-year historical (2017-2021) data projection of market size, segmentation, and region.

Technavio has announced its latest market research report titled Global Nerve Repair and Regeneration Market 2023-2027

Discover some insights on market size before buying the full report. Request a sample report.

Chart and data table on 5-year historic (2017-2021) market size, comparative analysis of segments, and Y-o-Y growth of nerve repair and regeneration market.

  • The market is segmented by product (neuromodulation devices and biomaterials), application (neurorrhaphy, nerve grafting, and stem cell therapy), and geography (North America, Europe, Asia, and Rest of World (ROW)).
  • Based on product, the neuromodulation devices segment will account for the highest share of the market's growth during the forecast period.
  • Neuromodulation is a technique that targets nerve injury by sending electrical impulses to the affected area. Neuromodulation surgical devices are well-known in the healthcare industry and have a high market share.

To procure the data - Buy report!

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak. The bargaining power of buyers & suppliers and the threat of new entrants, rivalry, and substitutes have also been analyzed and rated between MODERATE - HIGH to provide a holistic view of market favorability.

Find Technavio's exclusive analysis of price sensitivity, adoption lifecycle, customer purchase basket, adoption rates, and purchase criteria

  • One of the core components of the customer landscape is price sensitivity, an analysis of which will help companies refine marketing strategies to gain a competitive advantage. 
  • Another key aspect is price sensitivity drivers (purchases are undifferentiated, purchase is a key cost to buyers, and quality is not important), which range between LOW and HIGH.
  • Furthermore, market adoption rates for all regions have been covered.

The nerve repair and regeneration market report also offers information on the criticality of inputs, R&D, CAPEX, technology, and products of 15 vendors listed below –

  • ALEVA NEUROTHERAPEUTICS SA
  • AxoGen Inc.
  • Baxter International Inc.
  • BioWaveGO USA
  • Boston Scientific Corp.
  • Check Point Surgical Inc.
  • Collagen Matrix Inc.
  • Gimer Medical Co. Ltd.
  • Integra Lifesciences Holdings Corp.
  • KeriMedical SA
  • LivaNova Plc
  • Medtronic Plc
  • NEURONETICS Inc.
  • NeuroPace Inc.
  • NeuroSigma Inc.

Download a sample report

The rising prevalence of neurological disorders is notably driving the market growth

The nerve repair and regeneration market is expanding due to the rising prevalence of neurological illnesses like Alzheimer's disease across the world. Globally, the leading cause of impairment is neurological illnesses. According to the Centers for Disease Control and Prevention, about 5.8 million Americans suffered from Alzheimer's disease in 2020 in the US. Additionally, the aging population, which is more susceptible to these conditions, and the rising number of nerve injuries are boosting market expansion. 

Chart and data table on historical market size (2017-2021), historic industry size, and analysis of 15 vendors and 7 countries

The market is segmented by region (North America, Europe, Asia, and the Rest of World). An analysis of key leading countries has been included.

  • North America, which holds the major share of the market, is estimated to contribute 32% to the growth of the global market during the forecast period. The US is the major contributor to the nerve repair and regeneration market in North America, owing to the rising capital expenditure on treating patients with neurological disorders such as epilepsy and dementia and the growing demand for neuromodulation devices.
  • The increasing number of patients with neurological disorders and the increasing cost of treatment in the US are expected to boost market growth during the forecast period.

For Insights on the market dynamics and segmentations, VIEW A PDF SAMPLE!

Related Reports –

Peripheral Nerve Stimulators Market by Product, Stimulating Feature, and Geography – Forecast and Analysis 2021-2025: The peripheral nerve stimulators market size is forecasted to grow by USD 141.03 million during 2020-2025, and the market's growth momentum will accelerate at a CAGR of 5.25%. Furthermore, this report provides a detailed analysis of the market by product (transcutaneous, percutaneous, and implantable), stimulating feature (PNS-TOF and PNS), and geography (North America, Europe, Asia, and ROW).

Sacral Nerve Stimulation (SNS) Market by Product, End-user, and Geography – Forecast and Analysis 2020-2024: The sacral nerve stimulation (SNS) market size is forecasted to grow by USD 192.50 million during 2020-2024, and the market's growth momentum will accelerate during the forecast period. This report provides a detailed analysis of the market by product (implantable SNS devices and external SNS devices), end-user (hospitals and ASCs), and geography (APAC, Europe, North America, and ROW). 

Register for a trial today and gain instant access to 17,000+ market research reports. 
Technavio's SUBSCRIPTION platform

What are the key data covered in this nerve repair and regeneration market report?

  • CAGR of the market during the forecast period 2023-2027
  • Detailed information on factors that will assist nerve repair and regeneration market growth during the next five years
  • Estimation of the nerve repair and regeneration market size and its contribution to the parent market
  • Predictions on upcoming trends and changes in consumer behavior
  • The growth of the nerve repair and regeneration market
  • Analysis of the market's competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of nerve repair and regeneration market vendors

Nerve Repair And Regeneration Market Scope

Report Coverage

Details

Page number

153

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 11.23%

Market growth 2023-2027

USD 4,891.9 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

10.89

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 32%

Key countries

US, Canada, Germany, China, Japan, and India

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, ALEVA NEUROTHERAPEUTICS SA, AxoGen Inc., Baxter International Inc., BioWaveGO USA, Boston Scientific Corp., Check Point Surgical Inc., Collagen Matrix Inc., Gimer Medical Co. Ltd., Integra Lifesciences Holdings Corp., KeriMedical SA, LivaNova Plc, Medtronic Plc.

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table Of Contents :

1 Executive Summary

  • 1.1 Market Overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market Definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027
    • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
    • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
    • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
    • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global nerve repair and regeneration market 2017 - 2021
    • Exhibit 18: Historic Market Size – Data Table on Global nerve repair and regeneration market 2017 - 2021 ($ million)
  • 4.2 Product Segment Analysis 2017 - 2021
    • Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)
  • 4.3 Application Segment Analysis 2017 - 2021
    • Exhibit 20: Historic Market Size – Application Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021
    • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021
    • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers
    • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers
    • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants
    • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes
    • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry
    • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
  • 5.7 Market condition
    • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Product

  • 6.1 Market segments
    • Exhibit 30: Chart on Product - Market share 2022-2027 (%)
    • Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
  • 6.2 Comparison by Product
    • Exhibit 32: Chart on Comparison by Product
    • Exhibit 33: Data Table on Comparison by Product
  • 6.3 Neuromodulation devices - Market size and forecast 2022-2027
    • Exhibit 34: Chart on Neuromodulation devices - Market size and forecast 2022-2027 ($ million)
    • Exhibit 35: Data Table on Neuromodulation devices - Market size and forecast 2022-2027 ($ million)
    • Exhibit 36: Chart on Neuromodulation devices - Year-over-year growth 2022-2027 (%)
    • Exhibit 37: Data Table on Neuromodulation devices - Year-over-year growth 2022-2027 (%)
  • 6.4 Biomaterials - Market size and forecast 2022-2027
    • Exhibit 38: Chart on Biomaterials - Market size and forecast 2022-2027 ($ million)
    • Exhibit 39: Data Table on Biomaterials - Market size and forecast 2022-2027 ($ million)
    • Exhibit 40: Chart on Biomaterials - Year-over-year growth 2022-2027 (%)
    • Exhibit 41: Data Table on Biomaterials - Year-over-year growth 2022-2027 (%)
  • 6.5 Market opportunity by Product
    • Exhibit 42: Market opportunity by Product ($ million)

7 Market Segmentation by Application

  • 7.1 Market segments
    • Exhibit 43: Chart on Application - Market share 2022-2027 (%)
    • Exhibit 44: Data Table on Application - Market share 2022-2027 (%)
  • 7.2 Comparison by Application
    • Exhibit 45: Chart on Comparison by Application
    • Exhibit 46: Data Table on Comparison by Application
  • 7.3 Neurorrhaphy - Market size and forecast 2022-2027
    • Exhibit 47: Chart on Neurorrhaphy - Market size and forecast 2022-2027 ($ million)
    • Exhibit 48: Data Table on Neurorrhaphy - Market size and forecast 2022-2027 ($ million)
    • Exhibit 49: Chart on Neurorrhaphy - Year-over-year growth 2022-2027 (%)
    • Exhibit 50: Data Table on Neurorrhaphy - Year-over-year growth 2022-2027 (%)
  • 7.4 Nerve grafting - Market size and forecast 2022-2027
    • Exhibit 51: Chart on Nerve grafting - Market size and forecast 2022-2027 ($ million)
    • Exhibit 52: Data Table on Nerve grafting - Market size and forecast 2022-2027 ($ million)
    • Exhibit 53: Chart on Nerve grafting - Year-over-year growth 2022-2027 (%)
    • Exhibit 54: Data Table on Nerve grafting - Year-over-year growth 2022-2027 (%)
  • 7.5 Stem cell therapy - Market size and forecast 2022-2027
    • Exhibit 55: Chart on Stem cell therapy - Market size and forecast 2022-2027 ($ million)
    • Exhibit 56: Data Table on Stem cell therapy - Market size and forecast 2022-2027 ($ million)
    • Exhibit 57: Chart on Stem cell therapy - Year-over-year growth 2022-2027 (%)
    • Exhibit 58: Data Table on Stem cell therapy - Year-over-year growth 2022-2027 (%)
  • 7.6 Market opportunity by Application
    • Exhibit 59: Market opportunity by Application ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
    • Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
    • Exhibit 61: Chart on Market share by geography 2022-2027 (%)
    • Exhibit 62: Data Table on Market share by geography 2022-2027 (%)
  • 9.2 Geographic comparison
    • Exhibit 63: Chart on Geographic comparison
    • Exhibit 64: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
    • Exhibit 65: Chart on North America - Market size and forecast 2022-2027 ($ million)
    • Exhibit 66: Data Table on North America - Market size and forecast 2022-2027 ($ million)
    • Exhibit 67: Chart on North America - Year-over-year growth 2022-2027 (%)
    • Exhibit 68: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
    • Exhibit 69: Chart on Europe - Market size and forecast 2022-2027 ($ million)
    • Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
    • Exhibit 71: Chart on Europe - Year-over-year growth 2022-2027 (%)
    • Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
    • Exhibit 73: Chart on Asia - Market size and forecast 2022-2027 ($ million)
    • Exhibit 74: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
    • Exhibit 75: Chart on Asia - Year-over-year growth 2022-2027 (%)
    • Exhibit 76: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
    • Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
    • Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
    • Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
    • Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
    • Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
    • Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
    • Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 Germany - Market size and forecast 2022-2027
    • Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
    • Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
    • Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
    • Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.9 China - Market size and forecast 2022-2027
    • Exhibit 89: Chart on China - Market size and forecast 2022-2027 ($ million)
    • Exhibit 90: Data Table on China - Market size and forecast 2022-2027 ($ million)
    • Exhibit 91: Chart on China - Year-over-year growth 2022-2027 (%)
    • Exhibit 92: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.10 Canada - Market size and forecast 2022-2027
    • Exhibit 93: Chart on Canada - Market size and forecast 2022-2027 ($ million)
    • Exhibit 94: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
    • Exhibit 95: Chart on Canada - Year-over-year growth 2022-2027 (%)
    • Exhibit 96: Data Table on Canada - Year-over-year growth 2022-2027 (%)
  • 9.11 Japan - Market size and forecast 2022-2027
    • Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
    • Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
    • Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
    • Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • 9.12 India - Market size and forecast 2022-2027
    • Exhibit 101: Chart on India - Market size and forecast 2022-2027 ($ million)
    • Exhibit 102: Data Table on India - Market size and forecast 2022-2027 ($ million)
    • Exhibit 103: Chart on India - Year-over-year growth 2022-2027 (%)
    • Exhibit 104: Data Table on India - Year-over-year growth 2022-2027 (%)
  • 9.13 Market opportunity by geography
    • Exhibit 105: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
    • Exhibit 106: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape
    • Exhibit 107: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption
    • Exhibit 108: Overview on factors of disruption
  • 11.4 Industry risks
    • Exhibit 109: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered
    • Exhibit 110: Vendors covered
  • 12.2 Market positioning of vendors
    • Exhibit 111: Matrix on vendor position and classification
  • 12.3 Abbott Laboratories
    • Exhibit 112: Abbott Laboratories - Overview
    • Exhibit 113: Abbott Laboratories - Business segments
    • Exhibit 114: Abbott Laboratories - Key news
    • Exhibit 115: Abbott Laboratories - Key offerings
    • Exhibit 116: Abbott Laboratories - Segment focus
  • 12.4 ALEVA NEUROTHERAPEUTICS SA
    • Exhibit 117: ALEVA NEUROTHERAPEUTICS SA - Overview
    • Exhibit 118: ALEVA NEUROTHERAPEUTICS SA - Product / Service
    • Exhibit 119: ALEVA NEUROTHERAPEUTICS SA - Key offerings
  • 12.5 AxoGen Inc.
    • Exhibit 120: AxoGen Inc. - Overview
    • Exhibit 121: AxoGen Inc. - Product / Service
    • Exhibit 122: AxoGen Inc. - Key offerings
  • 12.6 Baxter International Inc.
    • Exhibit 123: Baxter International Inc. - Overview
    • Exhibit 124: Baxter International Inc. - Business segments
    • Exhibit 125: Baxter International Inc. - Key news
    • Exhibit 126: Baxter International Inc. - Key offerings
    • Exhibit 127: Baxter International Inc. - Segment focus
  • 12.7 Boston Scientific Corp.
    • Exhibit 128: Boston Scientific Corp. - Overview
    • Exhibit 129: Boston Scientific Corp. - Business segments
    • Exhibit 130: Boston Scientific Corp. - Key news
    • Exhibit 131: Boston Scientific Corp. - Key offerings
    • Exhibit 132: Boston Scientific Corp. - Segment focus
  • 12.8 Collagen Matrix Inc.
    • Exhibit 133: Collagen Matrix Inc. - Overview
    • Exhibit 134: Collagen Matrix Inc. - Product / Service
    • Exhibit 135: Collagen Matrix Inc. - Key offerings
  • 12.9 Integra Lifesciences Holdings Corp.
    • Exhibit 136: Integra Lifesciences Holdings Corp. - Overview
    • Exhibit 137: Integra Lifesciences Holdings Corp. - Business segments
    • Exhibit 138: Integra Lifesciences Holdings Corp. - Key news
    • Exhibit 139: Integra Lifesciences Holdings Corp. - Key offerings
    • Exhibit 140: Integra Lifesciences Holdings Corp. - Segment focus
  • 12.10 LivaNova Plc
    • Exhibit 141: LivaNova Plc - Overview
    • Exhibit 142: LivaNova Plc - Business segments
    • Exhibit 143: LivaNova Plc - Key offerings
    • Exhibit 144: LivaNova Plc - Segment focus
  • 12.11 Medtronic Plc
    • Exhibit 145: Medtronic Plc - Overview
    • Exhibit 146: Medtronic Plc - Business segments
    • Exhibit 147: Medtronic Plc - Key news
    • Exhibit 148: Medtronic Plc - Key offerings
    • Exhibit 149: Medtronic Plc - Segment focus
  • 12.12 NEURONETICS Inc.
    • Exhibit 150: NEURONETICS Inc. - Overview
    • Exhibit 151: NEURONETICS Inc. - Product / Service
    • Exhibit 152: NEURONETICS Inc. - Key offerings
  • 12.13 NeuroPace Inc.
    • Exhibit 153: NeuroPace Inc. - Overview
    • Exhibit 154: NeuroPace Inc. - Product / Service
    • Exhibit 155: NeuroPace Inc. - Key offerings
  • 12.14 Polyganics BV
    • Exhibit 156: Polyganics BV - Overview
    • Exhibit 157: Polyganics BV - Product / Service
    • Exhibit 158: Polyganics BV - Key offerings
  • 12.15 Soterix Medical Inc.
    • Exhibit 159: Soterix Medical Inc. - Overview
    • Exhibit 160: Soterix Medical Inc. - Product / Service
    • Exhibit 161: Soterix Medical Inc. - Key offerings
  • 12.16 Stryker Corp.
    • Exhibit 162: Stryker Corp. - Overview
    • Exhibit 163: Stryker Corp. - Business segments
    • Exhibit 164: Stryker Corp. - Key news
    • Exhibit 165: Stryker Corp. - Key offerings
    • Exhibit 166: Stryker Corp. - Segment focus
  • 12.17 Synapse Biomedical Inc.
    • Exhibit 167: Synapse Biomedical Inc. - Overview
    • Exhibit 168: Synapse Biomedical Inc. - Product / Service
    • Exhibit 169: Synapse Biomedical Inc. - Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
    • Exhibit 170: Inclusions checklist
    • Exhibit 171: Exclusions checklist
  • 13.3 Currency conversion rates for US$
    • Exhibit 172: Currency conversion rates for US$
  • 13.4 Research methodology
    • Exhibit 173: Research methodology
    • Exhibit 174: Validation techniques employed for market sizing
    • Exhibit 175: Information sources
  • 13.5 List of abbreviations
    • Exhibit 176: List of abbreviations
About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Global Nerve Repair and Regeneration Market 2023-2027

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nerve-repair-and-regeneration-market-2023-2027-growth-opportunities-led-by-abbott-laboratories-and-aleva-neurotherapeutics-sa---technavio-301698453.html

SOURCE Technavio

Werbung
Werbung
Werbung
Neue Funktionen als Erstes nutzen
Sie nutzen finanzen.net regelmäßig? Dann nutzen Sie jetzt neue Funktionen als Erstes!
Hier informieren!
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

Berichtssaison nimmt Fahrt auf: DAX geht kaum verändert ins Wochenende -- US-Börsen schließen im Plus -- Intel erleidet Gewinn- und Umsatzeinbruch -- Visa, Chevron, Mercedes-Benz, LVMH im Fokus

Ford ruft rund 462.000 Autos wegen mangelhafter Kameras zurück. Großaktionär stoppt Gespräche über Anteilsverkauf an PNE. Siemens Energy-Aktie: Wasserstoffallianz zwischen Deutschland und Australien. Schwelender Handelsstreit mit den USA: China hat den Ton verschärft. Lufthansa und Rom unterschreiben Absichtserklärung für Ita-Einstieg - Überprüfung von Firmensitz.

Umfrage

In Deutschland wird über eine mögliche Lieferung von Leopard-Panzern an die Ukraine diskutiert. Wie ist Ihre Meinung dazu?

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln